Stay updated on IDH-Targeted vs Non-Targeted Therapies in Newly Diagnosed AML Clinical Trial
Sign up to get notified when there's something new on the IDH-Targeted vs Non-Targeted Therapies in Newly Diagnosed AML Clinical Trial page.

Latest updates to the IDH-Targeted vs Non-Targeted Therapies in Newly Diagnosed AML Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedNew Revision: v3.3.3 appears on the page history, and 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' have been removed from the footer. These are administrative site-wide updates rather than study details or the core content of the trial record. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check34 days agoChange DetectedA new revision entry v3.3.2 was added to the Record History, and the previous revision v3.3.1 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check41 days agoChange DetectedA new revision entry v3.3.1 was added to the study record history, and the v3.2.0 entry was removed.SummaryDifference0.1%

- Check48 days agoChange DetectedThe banner notice about government funding and operating status was removed from the page. No study data, descriptions, or functionality appear to be affected.SummaryDifference0.7%

- Check62 days agoChange DetectedA new version entry dated 2025-05-14 was added to the Record History for NCT05401097, increasing the number of listed revisions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check91 days agoChange Detected- Added a government funding lapse notice and operating-status details, including the NIH Clinical Center openness and guidance to check cc.nih.gov and opm.gov. - Updated version from v3.1.0 to v3.2.0.SummaryDifference12%

Stay in the know with updates to IDH-Targeted vs Non-Targeted Therapies in Newly Diagnosed AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IDH-Targeted vs Non-Targeted Therapies in Newly Diagnosed AML Clinical Trial page.